Psychedelic Consciousness ( ex Unstoppable Technologies) – Telegram
Psychedelic Consciousness ( ex Unstoppable Technologies)
172 subscribers
40 photos
5 videos
7 files
400 links
Brain therapy: Between Science and Businesses

Psychedelic Consciousness research: DMT, LSD, MDMA, 5MEO-DMT, Ketamine, Psilocilybin, Ibogaine...

#Psychedelics #Consciousness #Neuroscience
Download Telegram
EMDR + Psychedelics = Match 

First I thought -WTF, those are 2 very powerful instruments.  why mixng?

Then I remember myself trying to do that with Ketamine long time ago with the idea that it might help me to enter the EMDR season and get rid of the blocks i had, but my experiment was not successful that time.

So how we can mix EMDR with psychedelics?

1. As a preparation session before to get to trauma
2. As a tool to get out from repeating loop happening during psychedelic therapy (research in going on in this area)
3. As a better way to use neuroplasticity window after psychedelic to run even better integration 
4. Microdosing to enhance EMDR

What are the combinations
1. EMDR + weed to increase body connection 
2. EMDR + MDMA - perfect match
3. EMDR + Ketamine - there is a research that it's actually make sense in low doses (maybe I need to try again)
4. EMDR + Classic Psychedelic - great too to process and integrate  all insights clothes to the end of trip 


P.S. there was a short conversation on flashbacks  and theory that it's actually a Version of PTSD
When part of the trip was not processed properly and then stored in maladaptive part , like traumatic memory. I found this very insightful and wan to dive deeper. 

https://podcasts.google.com/feed/aHR0cHM6Ly9wbGFudG1lZGljaW5lcG9kY2FzdC5saWJzeW4uY29tL3Jzcw/episode/ZDY4NmY5MDctMmFiNC00NmNjLWIxNzUtY2RkZjNiYjcxY2M4?ep=14
1
Psychedelic digest January 2024 

Let's try new format, since I've been out of this reality ( well, I was  actually testing a bunch of altered states of consciousness with Psychedelics, Breathwork, Soundhealing, Nidra and others, and still processing it )😊

Here is the digest of most interesting Psychedelic news in Jan 2024 from Business, Clinical and Research areas. 


Business & Government 

Following the approved psychedelics provision,l and 10m$ in funding the Department of Defense (DoD) must create, within 180 days of the enactment, a process for service members with post-traumatic stress disorder (PTSD) or traumatic brain injury (TBI) to participate in clinical trials with psilocybin, MDMA, ibogaine or 5-MeO-DMT.

https://www.benzinga.com/markets/cannabis/23/12/36386091/president-biden-approves-psychedelics-clinical-trials-for-active-military-members

 Development and Clinical trials 

1. MindMed, a biotech company specializing in psychedelic-inspired medicines, has revealed promising results from its MM-120 drug candidate in the treatment of Generalized Anxiety Disorder (GAD).

The trial highlight that the drug candidate, particularly at the 100 µg dose, demonstrated effectiveness, significantly reducing anxiety symptoms.

https://www.medicalnewstoday.com/articles/lsd-effective-treating-anxiety-clinical-trial



2. Cybin Announces Positive Topline Data from Phase 1 Studies of Proprietary Deuterated DMT Molecules CYB004 and SPL028

Importantly, these are the first-in-human studies of deuterated DMT in healthy participants. both the IV and IM administrations produced robust psychedelic effects and were safe and well-tolerated

Results  support progression to a Phase 2 study in Q1 2024

https://financialpost.com/pmn/business-wire-news-releases-pmn/cybin-announces-positive-topline-data-from-phase-1-studies-of-proprietary-deuterated-dmt-molecules-cyb004-and-spl028

Science and Research 

And now, the favorite part. For this month I've picked something less usual as we regularly see. Less common psychedelics (Ibogaine), less common sickness (/brain injury) and my favorite, less common way to search for a new drugs( AI).


1. Psychedelics for acquired brain injury (ABI): a review of molecular mechanisms and therapeutic potential


Paper explores the neurochemical properties of psychedelics as a therapeutic intervention for ABI, with a focus on serotonin receptors, sigma-1 receptors, and neurotrophic signalling associated with neuroprotection, neuroplasticity, and neuroinflammation. The promotion of neuronal growth, cell survival, and anti-inflammatory properties exhibited by psychedelics strongly supports their potential benefit in managing ABI.

https://www.nature.com/articles/s41380-023-02360-0

2.  Ibogaine for Traumatic brain injury 

TBI is a leading cause of injury-related disability worldwide and is likely to remain so until at least 2030. It is also the signature injury of US veterans from recent military conflicts, most often caused by blast exposure.

The prespecified primary outcome was a change in the World Health Organization Disability Assessment Schedule 2.0 from baseline to posttreatment.


https://www.nature.com/articles/s41591-023-02705-w


3.  Alphaphold AI discovered new psychedelics

Researchers have used the protein-structure-prediction tool AlphaFold to identify hundreds of thousands of potential new psychedelic molecules — which could help to develop new kinds of antidepressant.

They then synthesized hundreds of the most promising compounds identified with either the predicted and experimental structures and measured their activity in the lab.

The screens with predicted and experimental structures yielded completely different drug candidates.

But to the team’s surprise, the ‘hit rates’ — the proportion of flagged compounds that actually altered protein activity in a meaningful way — were nearly identical for the two groups. And AlphaFold structures identified the drugs that activated the serotonin receptor most potently. 

https://www.nature.com/articles/d41586-024-00130-8
👍1🔥1
HPPD or hallucinogen persisting perception disorder.

Just recently though if there are any good studies on this "flashbacks" phenomenon and here they are:

"One of the most notable findings was the correlation between first-time psychedelic use and an increase in unusual visual experiences. Participants who had never before used psychedelics but did so during the study period reported a greater increase in these experiences than individuals who had used psychedelics previously. This suggests that naivety to psychedelics may predispose individuals to more pronounced visual disturbances, highlighting a potential area of concern for first-time users


https://www.psypost.org/2024/02/psychedelic-use-linked-to-increased-risk-of-unusual-visual-experiences-221224
👍2
Brain organoids breakthrough 😊


"Scientists have created brain “organoids” for years, but there are limitations to the tiny, lab-grown cultures. One of the most frustrating issues is a lack of control over their design, which often limits an organoid’s functionality and use. Although researchers long suspected 3D-printing could offer a solution, the workaround has so far proven difficult and ineffective. A new production breakthrough, however, could solve the longstanding barrier, and one day offer new ways of exploring treatment for diseases such as Parkinson’s and Alzeheimer’s."

And we will be finally able to test psychedelics on organoids 😊


https://www.popsci.com/science/3d-printed-brain-tissue/
🔥2
Psychedelics and Sex ❤️

14th February is close, plan your plans accordingly 😘

These are the findings of the first known scientific investigation into the effects of psychedelics on sex by Imperial College London. questionnaire responses from almost 300 people before and after a psychedelic experience.

By combining responses from two groups – people taking psychedelics for recreational or wellness/ceremonial purposes, as well as a small group from a clinical trial assessing psylocibin (the compound found in magic mushrooms) for depression – they were able to investigate how the experience influenced a range of aspects relating to sexual functioning.


The analysis reveals that on average, people reported improvements across a range of areas of sexual function up to six months after their psychedelic experience, including their enjoyment of sex, sexual arousal, satisfaction with sex, attraction to partner, their own physical appearance, communication, and their sense of connection.



https://www.imperial.ac.uk/news/251313/psychedelic-experiences-linked-with-improved-sexual/
4
Sovereign funds looking to invest in Psychedelics 🥳

January was the second-highest month on record for funding of the psychedelics sector

Groups seeking to harness mind-altering substances including MDMA, psilocybin mushrooms, pictured at right, and 5-MeO-DMT raised at least $163mn across five deals in January

Sovereign wealth funds Temasek and Mubadala in talks to fund biotech groups harnessing mind-altering substances!

This is huge 😎




https://www.ft.com/content/4a2e856c-4736-4b8b-9323-583bb1dbe8f4
😎1
DMT research must be legal 👊


"The reality that we experience, waking reality is marely a fraction of consciousness states that exist and if we prevent ourselves from studying those altered states of consciousness we will never have a complete understanding of the universe."  

https://youtu.be/LFnCwXPjSCk?si=sqchEfYs4p1B1Omn
💯2
LSD, Homosexuality, WW2, Mk ultra, Weekend's history reading

"Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science"

Looks like a new amazing book about psychedelics.😀


Margaret Mead was among the most famous scientists of the 20th century. Despite this, however, her role in the early history of psychedelic research has gone strangely unnoticed.
In this excerpt from my new book Tripping on UtopiaMargaret Mead, recently returned from months of anthropological fieldwork studying an apocalyptic religious movement known as the Noise on the remote island of Manus, becomes involved in the early LSD experiments of Harold Alexander Abramson—and begins planning to take the drug herself.

Mead’s most important source for information about psychedelics at this time was Dr. Harold Abramson, an allergist and expert in “psychosomatic” illnesses. Among other things, Abramson had shared with her the results of an LSD trial that resulted in what he called “loss of fear of homosexuality”: a woman racked by anxiety over her suspicion that she might be a lesbian had, under the drug, resolved her fears. Mead, who was in a committed, yearslong relationship with fellow anthropologist Rhoda Métraux by this time, absorbed this information with great interest. Perhaps LSD could speed up the rate at which global culture adapted to rapid change. Perhaps, as she wrote to herself in June 1954, the drug could be a “short cut” for pulling society “away from mysticism and escape.”


https://slate.com/news-and-politics/2024/02/tripping-on-utopia-book-lsd-psychedelics-history.html
Psychedelic facilitator requirements 😎


In the wake of psychedelic legalization in Colorado, a state board is outlining proposed training requirements for psychedelic "facilitators."

36 pages PDF is attached

https://www.9news.com/article/news/health/colorado-releases-proposed-rules-for-psychedelic-therapy-guides/73-4febfab5-e298-46fb-9f28-bd6768eb86c9
👏2
🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥

Breaking: Group MDMA therapy trail launched in Israel.

The first cohort of October 7 victims started today by MAPS Israel.
🔥5👍32
MAPS-Integration-Workbook.pdf
1.2 MB
Psychedelic integration guide 🔥

MAPS just released a new Psychedelics Integration guide. So far it's probably the best document in this area.
🔥3
Have Anxiety? Take LSD🤪

LSD now officially and efficiently can help with anxiety with only 100ug dose. What do I think? Hmmm. Yes, god damn it, we already know it 😂.

Some history facts:

2013 breakthrough FDA for Ketamine
2017 breakthrough FDA for MDMA
2018 breakthrough FDA for Psilocybin
2024 breakthrough FDA for LSD 😎<- we are here


"breakthrough designation is a recognition that a drug has demonstrated evidence of clinical efficacy in meeting an unmet medical need with morbidity and mortality associated with it,”

MindMed plans to hold an End-of-Phase 2 meeting with the U.S. Food & Drug Administration (FDA) in the first half of 2024 and initiate its Phase 3 clinical program in the second half of 2024


https://www.businesswire.com/news/home/20240307733599/en/
🔥32🌚1
New research on LSD Microdosing

Let it be the week of LSD 🤪

It was found that 26 micrograms of LSD  increased brain complexity by about 12 percent compared to a placebo, without altering consciousness.


The trials were repeated in two further groups, one with moderate (7.5 mg) and high (15 mg) doses of tetrahydrocannabinol (THC) from cannabis and one with medical methamphetamine at doses of 10 mg and 20 mg. In these experiments, THC, but not methamphetamine, affected consciousness at high doses.


The team's analysis of all the trials found only the 26-microgram dose of LSD had a significant effect on neural complexity, increasing it by approximately 12 percent on average when compared to the placebo"


I've personally found 50 micrigram dose very effective for a variety of things from self-healing and meditation to sex and learning new skills. However i tried this microdosing size of approximately 20 mcg just few times and it's definitely a big room for exploring the best application for such dose. 

Will soon write some guides on LSD mini-dosing 😁



https://www.sciencealert.com/tiny-doses-of-lsd-boost-unique-signals-in-the-human-brain
👍4😁21
150m$ for Mushrooms startup 🙃

Cybin Announces Closing of the Oversubscribed Private Placement of U.S. $150 Million

The net proceeds of the Private Placement are expected to be used for certain Phase 3 drug development activities for CYB003, working capital and general corporate purposes. CYB003, is a proprietary deuterated psilocybin analog in development for the potential treatment of Major Depressive Disorder ("MDD"). If approved by the U.S. Food and Drug Administration (the "FDA"), CYB003 would be the first known adjunctive psychedelic-based therapeutic for the treatment of MDD.


https://finance.yahoo.com/news/cybin-announces-closing-oversubscribed-private-155300089.html
👍21
How I ate 40g of Mushrooms or measuring shrooms dose.

Actually this new research on measuring Psilocilybin in mushrooms is quite important. I've recently eaten 40gramms of some mushrooms which were offered to me as one dose.

I was a bit shocked as usually it should be 10-20 times less for one dose. But as a curious researcher I gave it a try 😅.

As you can see I'm still here and alive, though I had some conversations with entities 🙃. But subjustively it was similar to one dose.

So back to the research:

New technique measures psilocybin potency of mushrooms

Using 
liquid chromatography with tandem mass spectrometry, Schug and colleagues were able to extract and measure the strength of the mushrooms.

https://phys.org/news/2024-03-technique-psilocybin-potency-mushrooms.html
🔥21🤡1
Psychedelic digest march 2024.

Sorry, sorry I spent a month in Ubud and barely had time to post on a daily basis,but I carefully read all important news and here are the top ones for you and it's not a joke 🤣

Top important psychedelic news from Market, Research, Religion, Education, Industry,  Investment and Government. 


# Top Psychedelic Religion news


First Church in USA in the way to "legalize" the use of Ayahuasca 

https://www.chronline.com/stories/psychedelic-washington-church-working-toward-legal-immunity-to-consume-ayahuasca,335768?


# Top Psychedelics Education

Minor degree in Psychedelics opened in University of Boulder

https://www.9news.com/video/news/education/naropa-university-boulder-minor-psychedelics-mushrooms/73-5c670769-61a4-4ab3-8e49-0bd1aa584474

As well is in Naropa university! Wow! Two programs in one month

https://finance.yahoo.com/news/naropa-university-launches-pioneering-psychedelic-113400650.html

How to check quickly what is true and what is bullshit in Psychedelics

https://www.psychologytoday.com/us/blog/being-awake-better/202403/8-ways-to-learn-about-psychedelics


#Top psychedelic clinical trials

Psyched's intranasal 5-MEO-DMT passed phase 2 for Threatmen resident depression 😊

https://www.pharmabiz.com/NewsDetails.aspx?aid=168226&sid=2



#TOP Government psychedelic actions

https://www.marijuanamoment.net/u-s-company-offers-free-psychedelics-training-services-to-ukraine-health-professionals-to-treat-trauma-from-war-with-russia/

Fluence - a psychedelic Startup together with 
 Ukrainian Psychedelic Research Association (UPRA) and the U.S. nonprofit Heal Ukraine Trauma (HUT),  is providing free training materials for psychologists and medical doctors who are interested in incorporation psychedelics into their practices.

Unlike medical cannabis, psychedelics have not been legalized in Ukraine. Even so, more than 540 mental health professionals have already signed up for the program, Fluence said.

# Top Psychedelic Patent news

https://finance.yahoo.com/news/breakthrough-wellness-clearmind-medicines-psychedelic-115500300.html

Psychedelic Patent in China, that's interesting. 

MEAI is a new psychoactive molecule that reduces desire to consume alcoholic beverages and exerts a slight euphoric, alcohol-like experience with potential to change the lives of millions who struggle to drink in moderation. Clearmind’s MEAI-based flagship treatment focuses on Alcohol Use Disorder, which is incredibly common.


# Top Psychedelic Market news 

MOXY - new kid in Psychedelic renaissance

Mindstate Design Labs uses AI to find the best candidate for psychedelic assistant therapy.

Mindstate Design Labs has submitted its first IND, asking the FDA to greenlight a clinical trial for its lead asset targeting 5-MeO-MiPT, also known as moxy, a psychedelic selected from more than 70,000 “trip reports” to classify states of consciousness

Using large language models and natural language processing, Mindstate has built a platform that segments experiences by drug or psychedelic receptors. In some cases, the platform can visualize an experience, like color transformations

https://www.fiercebiotech.com/biotech/mindstates-first-ai-derived-psychedelic-heads-clinic
🔥41